Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

Size: px
Start display at page:

Download "Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014"

Transcription

1 Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011 EAU 2014 BPH Guidelines CUA 2009 AUA 2010 EAU

2 Grade Nature of Recommendations A - Based on clinical studies of good quality and consistency that addressed the specific recommendations, including at least one randomised trial. B - Based on well-conducted clinical studies, but without randomised clinical trials. C - Made despite the absence of directly applicable clinical studies of good quality. ED Evaluation Medical and psychosexual history (use of validated instruments, e.g. IIEF) Identify other than ED sexual problems Identify common causes ED Vasculogenic Neurogenic: Central & Peripheral Anatomical Hormonal Drug-induced Psychogenic Trauma Identify reversible risk factors for ED Assess psychosocial status 2

3 Focused physical examination Penile deformities Prostatic disease Signs of hypogonadism Cardiovascular and neurological status Laboratory tests Glucose-lipid profile Total testosterone Treatment algorithm for determining level of sexual activity according to cardiac risk in ED Exercise ability Low risk (able to perform exercise of modest intensity) - Advice, treat ED High risk (moderate-tosevere symptomatic heart disease) Cardiologist Intermediate risk - Stress test Low or high risk 3

4 B - Clinical use of validated questionnaire related to ED may help to assess all sexual function domains and the effect of a specific treatment modality. B - Physical examination is needed in the initial assessment of men with ED to identify underlying medical conditions that may be associated with ED. B - Routine laboratory tests, including glucose-lipid profile and total testosterone, are required to identify and treat any reversible risk factors and lifestyle factors that can be modified. B - Specific diagnostic tests are indicated by only a few conditions. Treatment of ED Identify and treat curable causes of ED Lifestyle changes and risk factor modification Provide education and counselling to patients and partners Identify patient needs and expectations, Shared decision-making, Offer conjoint psychosocial and medical treatment 4

5 PDE5 inhibitors Intracavernous injections, Vacuum devices, Intraurethral alprostadil Assess therapeutic outcome: Erectile response, Side-effects, Treatment satisfaction Consider penile prosthesis implantation A - Lifestyle changes and risk factor modification must precede or accompany ED treatment. A - Pro-erectile treatments have to be given at the earliest opportunity after RP. B - When a curable cause of ED is found, it must be treated first. A - PDE5Is are first-line therapy. B - Inadequate prescription and poor patient education are the main causes of a lack of response to PDE5Is. C - A VED can be used in patients with a stable relationship. B - Intracavernous injection is second-line therapy. C - Penile implant is third-line therapy. 5

6 BPH in the RED words A - A medical history must always be taken from men with LUTS. B - A validated symptom score questionnaire with QoL question(s) should be used for the routine assessment of male LUTS in all patients and should be applied for re-evaluation of LUTS during treatment. B - Micturition frequency volume charts (FVC) or bladder diaries should be used to assess male LUTS with a prominent storage component or nocturia. B - FVCs should be performed for the duration of at least 3 days. B - Physical examination including DRE should be a routine part of the assessment of male LUTS. A* - Urinalysis (by dipstick or urinary sediment) must be used in the assessment of male LUTS. (* Upgraded by Panel consensus) A - PSA measurement should be performed only if a diagnosis of PCa will change the management or if PSA can assist in decision-making in patients at risk of progression of BPE. A* - Renal function assessment must be performed if renal impairment is suspected, based on history and clinical examination or in the presence of hydronephrosis or when considering surgical treatment for male LUTS. B - Measurement of post-void residual (PVR) in male LUTS should be a routine part of the assessment. 6

7 B - Imaging of the upper urinary tract (with US) in men with LUTS should be performed in patients with a large PVR, haematuria or a history of urolithiasis. B - When considering medical treatment for male LUTS, imaging of the prostate (either by TRUS or transabdominal US) should be performed if it assists the choice of the appropriate drug. B - Urethrocystoscopy should be performed in men with LUTS to exclude suspected bladder or urethral pathology and/or prior to surgical therapies if the findings may change treatment. 7

8 Treatment A - Men with mild symptoms are appropriate for watchful waiting A - Men with LUTS should always be offered lifestyle advice prior to or concurrent with treatment A - Alpha1-blockers can be offered to men with moderate-to-severe LUTS A - 5a-Reductase inhibitors can be offered to men who have moderate-to-severe LUTS and an enlarged prostate (>40 ml) A - 5a-Reductase inhibitors can prevent disease progression with regard to acute urinary retention and the need for surgery B - Muscarinic receptor antagonists may be used in men with moderate-to-severe LUTS who predominantly have bladder storage symptoms C - Carefulness with muscarinic receptor antagonists is advised in men with BOO A - PDE type 5 inhibitors reduce moderate-to-severe (storage and voiding) LUTS in men with or without erectile dysfunction. Only tadalafil (5 mg once daily) has been licensed for the treatment of male LUTS in Europe No recommendations were made about phyotherapy 8

9 A - Vasopressin analogue can be used for the treatment of nocturia due to nocturnal polyuria A - Combination treatment with an a1-blocker together with a 5areductase inhibitor can be offered to men with bothersome moderate-to-severe LUTS, enlarged prostate and reduced Qmax (men likely to develop disease progression) B - Combination treatment with an a1-blocker together with a muscarinic receptor antagonist may be used in patients with bothersome moderate-to-severe LUTS if relief of storage symptoms has been insufficient with monotherapy with either drug B - Combination treatment with anti muscarinics should be prescribed with caution in men who may have BOO Surgery A - TURP is the current surgical standard procedure for men with prostate sizes of ml and bothersome moderate-to-severe LUTS secondary of BPH. TURP provides subjective and objective improvement rates superior to medical therapy. A - Open prostatectomy or holmium laser enucleation (HoLEP) is the first choice of surgical treatment in men with prostate sizes > 80 ml and bothersome moderate-to-severe LUTS secondary to BPH needing surgical treatment. A - Open prostatectomy is the most invasive surgical method with significant morbidity. 9

10 A - HoLEP and 532-nm laser vaporization of the prostate are alternatives to TURP in men with moderate-to-severe LUTS due to BPO leading to immediate, objective, and subjective improvements comparable with TURP. A - The intermediate-term functional results of 532-nm laser vaporization of the prostate are comparable with TURP. A - With regard to intra-operative safety, 532-nm laser vaporization is superior to TURP. B nm laser vaporization should be considered in patients receiving anticoagulant medication or with a high cardiovascular risk. C - Intraprostatic BTX injections for men with bothersome moderateto-severe LUTS secondary to BPH or men in urinary retention are still experimental and should be performed only in clinical trials. GreenLight Laser Day surgery vs 1-2 day stay Low bleeding risk since the vessels are coagulated during the procedure No risk of TURP syndrome (dilutional hyponatremia) since the vessels are sealed Works about as well at conventional TURP 10

11 GreenLight Laser Propaganda from AMS GreenLight laser therapy uses laser light rather than thermal or electrical energy to remove obstructive tissue. 3 GreenLight 532nm wavelength vaporizes prostate tissue without charring and limits penetration, leaving a thin rim of coagulated tissue that aids in hemostasis.1 3 GreenLight laser therapy utilizes a non-contact, liquid cooled fiber to protect the fiber from tissue damage. This reduces the possible need to use multiple fibers during a procedure. 3 GreenLight laser therapy is not contraindicated for patients with pacemakers, defibrillators or neuro-stimulators. The GreenLight laser system is contraindicated for patients who have calcified tissue, require hemostasis in >2mm vessels and have uncontrolled bleeding disorders. See Operator s Manual and any accompanying instructions for use for a complete listing.2 3 GreenLight has been found to cost less than TURP while providing similar clinical outcomes.3, 8 3 Randomized controlled studies have shown that GreenLight has low complication rates, and short catheterization and hospitalization times.4, 5, 6, 7, 8 Possible risks and complications include, but are not limited to, irritative symptoms (dysuria, urgency, frequency), retrograde ejaculation, urinary incontinence, erectile dysfunction, hematuria - gross, UTI, bladder neck contracture/outlet obstruct, urinary retention, perforation - prostate, urethral stricture.2 3 TUR syndrome is not a postoperative complication with GreenLight.7, 8, 9 3 The GreenLight procedure has no overall deleterious impact on sexual function.10 3 GreenLight can be used for patients on anticoagulants, in urinary retention or who have large glands >100 ml.9, 11 3 GreenLight requires no post procedure irrigation or morcellation to remove tissue fragments as part of the procedure. 3 All costs incurred in getting the patient to a BPH symptom-free status should be considered (total economic impact of any treatment = procedural costs, costs associated with hospital length of stay, and the number of reinterventions). 11

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (BPO)

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (BPO) GUIDELINES ON NON-NEUROGENIC MLE LUTS INCLUDING BENIGN PROSTTIC OBSTRUCTION (BPO) (Text update pril 2014) S. Gravas (chair),. Bachmann,. Descazeaud, M. Drake, C. Gratzke, S. Madersbacher, C. Mamoulakis,

More information

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION

GUIDELINES ON NON-NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION GUIDELINES ON NON-NEUROGENIC MLE LUTS INCLUDING BENIGN PROSTTIC OBSTRUCTION (Text update March 2015) S. Gravas (Chair), T. Bach,. Bachmann, M. Drake, M. Gacci, C. Gratzke, S. Madersbacher, C. Mamoulakis,

More information

EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION

EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (Limited text update March 2016) S. Gravas (Chair), T. Bach, A. Bachmann, M. Drake, M. Gacci, C. Gratzke, S. Madersbacher,

More information

EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION

EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION EAU GUIDELINES ON NON- NEUROGENIC MALE LUTS INCLUDING BENIGN PROSTATIC OBSTRUCTION (Text update March 2017) S. Gravas (Chair), T. Bach, M. Drake, M. Gacci, C. Gratzke, T.R.W. Herrmann, S. Madersbacher,

More information

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablative therapies, transurethral needle ablation, Adverse events, sexual side effects of BPH Aging, and incidence of BPH associated with

More information

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of

More information

Management of LUTS. Simon Woodhams February 2012

Management of LUTS. Simon Woodhams February 2012 Management of LUTS Simon Woodhams February 2012 The management of lower urinary tract symptoms (LUTS) in men Implementing NICE guidance May 2010 NICE clinical guideline 97 Background Lower urinary tract

More information

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Diagnostic approach to LUTS in men Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Classification of LUTS Storage symptoms Voiding symptoms Post micturition

More information

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,

More information

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size

More information

LUTS after TURP: How come and how to manage? Matthias Oelke

LUTS after TURP: How come and how to manage? Matthias Oelke LUTS after TURP: How come and how to manage? Matthias Oelke Department of Urology Global Congress on LUTD, Rome, 26 th June 2015 Disclosures Consultant, speaker, trial participant and/or research grants

More information

Treating BPH: Comparing Rezum UroLift and HoLEP

Treating BPH: Comparing Rezum UroLift and HoLEP Treating BPH: Comparing Rezum UroLift and HoLEP Scott M. Cheney MD Mayo Clinic Arizona 2018 MFMER slide-1 Welcome to AZ 2018 MFMER slide-2 Outline Background on BPH, Rezum, Urolift, HoLEP AUA Guideline

More information

Management of Voiding Problems in Older Men. Dr. John Fenn Consultant, QEH 10 th October, 2005

Management of Voiding Problems in Older Men. Dr. John Fenn Consultant, QEH 10 th October, 2005 Management of Voiding Problems in Older Men Dr. John Fenn Consultant, QEH 10 th October, 2005 Voiding Problems Poor stream Hesitancy Straining Incomplete emptying Intermittent micturition Terminal dribbling

More information

EAU GUIDELINES POCKET EDITION 3

EAU GUIDELINES POCKET EDITION 3 EAU GUIDELINES POCKET EDITION 3 CONTENTS: BENIGN PROSTATIC HYPERPLASIA URINARY INCONTINENCE UROLITHIASIS 2 3 EAU POCKET GUIDELINES POCKET EDITION 3 This is one of a series of convenient pocket size books

More information

Benign Prostatic Hyperplasia (BPH):

Benign Prostatic Hyperplasia (BPH): Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate

More information

Initial Experience of High Power Diode Laser for Vaporization of Prostate Muhammad Rafiq Zaki, Mujahid Hussain, Tahir Mehmood, Murtaza Hiraj

Initial Experience of High Power Diode Laser for Vaporization of Prostate Muhammad Rafiq Zaki, Mujahid Hussain, Tahir Mehmood, Murtaza Hiraj Original Article Initial Experience of High Power Diode Laser for Vaporization of Prostate Muhammad Rafiq Zaki, Mujahid Hussain, Tahir Mehmood, Murtaza Hiraj Abstract Objectives: Prospective evaluation

More information

Rezūm procedure for the Prostate

Rezūm procedure for the Prostate Rezūm procedure for the Prostate Mr Jas Kalsi Consultant Urological Surgeon This booklet has been provided to help answer the questions you may have with regards to your enlarged prostate and the Rezūm

More information

Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH) Benign Prostatic Hyperplasia (BPH) Definition Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH), prostate gland enlargement can cause bothersome

More information

Male Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon

Male Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon Male Lower Urinary Tract Symptoms: Management in primary care and beyond Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon 1 LUTS Very common: 1/3 men over age of 50 have moderate to severe LUTS

More information

Diagnosis and Mangement of Nocturia in Adults

Diagnosis and Mangement of Nocturia in Adults Diagnosis and Mangement of Nocturia in Adults Christopher Chapple Professor of Urology Sheffield Teaching Hospitals University of Sheffield Sheffield Hallam University UK 23 rd October 2015 Terminology

More information

Original Policy Date

Original Policy Date MP 7.01.39 Transurethral Microwave Thermotherapy Medical Policy Section Surgery Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical

More information

What should we consider before surgery? BPH with bladder dysfunction. Inje University Sanggye Paik Hospital Sung Luck Hee

What should we consider before surgery? BPH with bladder dysfunction. Inje University Sanggye Paik Hospital Sung Luck Hee What should we consider before surgery? BPH with bladder dysfunction Inje University Sanggye Paik Hospital Sung Luck Hee Diagnostic tests in three categories Recommendation: there is evidence to support

More information

All about the Prostate

All about the Prostate MEN S HEALTH Dr Nick Pendleton January 16 th 2018 All about the Prostate 1 What does it do? Functions of the Prostate 1. Secretes Prostatic Fluid slightly alkaline fluid, 30% of volume of seminal fluid,

More information

BPH / LUTS. Prevalence. Prevalence of BPH. It is abnormal NOT to have benign growth of the prostate with increasing age. Prevalence.

BPH / LUTS. Prevalence. Prevalence of BPH. It is abnormal NOT to have benign growth of the prostate with increasing age. Prevalence. BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG FECSM Beaconsfield Medical Practice, Brighton & Brighton & Sussex Universities NHS Trust As man draws near the common goal Can anything be sadder Than he

More information

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms?

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms? PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS What is Benign Prostatic Hyperplasia (enlarged prostate)? Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate, the gland that

More information

EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO)

EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO) EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO) S. Gravas (Chair), J.N. Cornu, M.J. Drake, M. Gacci, C. Gratzke, T.R.W.

More information

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate NOTE: This policy is not effective until April 1, 2019. Medical Policy Manual Surgery, Policy No. 210 Transurethral Water Vapor Thermal Therapy of the Prostate Next Review: December 2019 Last Review: December

More information

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA St. Louis Hospital PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA INITIAL CLINICAL RESULTS Faculty of Medical Sciences New University of Lisbon JOÃO PISCO LUÍS CAMPOS PINHEIRO TIAGO BILHIM HUGO RIO TINTO

More information

Consensus Meeting for Asian-Pacific BPH Guideline

Consensus Meeting for Asian-Pacific BPH Guideline Consensus Meeting for Asian-Pacific BPH Guideline Byung Ha Chung Yonsei University Health System S a t e l l i t e S y m p o s i u m I Contents Diagnosis and Treatment Guidelines for BPH Prostate Volume

More information

MODULE 3: BENIGN PROSTATIC HYPERTROPHY

MODULE 3: BENIGN PROSTATIC HYPERTROPHY MODULE 3: BENIGN PROSTATIC HYPERTROPHY KEYWORDS: Prostatic hypertrophy, prostatic hyperplasia, PSA, voiding dysfunction, lower urinary tract symptoms (LUTS) At the end of this clerkship, the medical student

More information

Clinical guideline Published: 23 May 2010 nice.org.uk/guidance/cg97

Clinical guideline Published: 23 May 2010 nice.org.uk/guidance/cg97 Lower urinary tract symptoms in men: management Clinical guideline Published: 23 May 2010 nice.org.uk/guidance/cg97 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5 BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG Beaconsfield Medical Practice, Brighton As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder

More information

Policy for Prostatism/Lower Urinary Tract Symptoms in men

Policy for Prostatism/Lower Urinary Tract Symptoms in men NHS Halton Clinical Commissioning Group NHS Liverpool Clinical Commissioning Group NHS St Helens Clinical Commissioning Group NHS South Sefton Clinical Commissioning Group NHS Southport and Formby Clinical

More information

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Benign Prostatic Hyperplasia Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied,

More information

The Enlarged Prostate Symptoms, Diagnosis and Treatment

The Enlarged Prostate Symptoms, Diagnosis and Treatment The Enlarged Prostate Symptoms, Diagnosis and Treatment MAC00031-01 Rev G Financial support for this seminar has been provided by NeoTract, Inc., the manufacturer of the UroLift System. 1 Today s Agenda

More information

Early-Stage Clinical Experiences of Holmium Laser Enucleation of the Prostate (HoLEP)

Early-Stage Clinical Experiences of Holmium Laser Enucleation of the Prostate (HoLEP) JRural Med 2007 ; 2 : 93 97 Original article Early-Stage Clinical Experiences of Holmium Laser Enucleation of the Prostate (HoLEP) Shuzo Hamamoto 1,TakehikoOkamura 1,HideyukiKamisawa 1,KentaroMizuno 1,

More information

Office Management of Benign Prostatic Enlargement

Office Management of Benign Prostatic Enlargement Focus on CME at McGill University Office Management of Benign Prostatic Enlargement Symptomatic benign prostate enlargement is a common medical problem encountered in our aging society. Watchful waiting,

More information

What is Benign Prostatic Hyperplasia (BPH)?

What is Benign Prostatic Hyperplasia (BPH)? What is Benign Prostatic Hyperplasia (BPH)? Benign prostatic hyperplasia (BPH) is an enlarged prostate. The prostate goes through two main growth periods as a man ages. The first occurs early in puberty,

More information

GREENLIGHT XPS LASER THERAPY SYSTEM: A SYSTEMATIC APPROACH TO VAPORIZATION

GREENLIGHT XPS LASER THERAPY SYSTEM: A SYSTEMATIC APPROACH TO VAPORIZATION TM GREENLIGHT XPS LASER THERAPY SYSTEM: A SYSTEMATIC APPROACH TO VAPORIZATION Gregg R. Eure, MD, FACS Urology of Virginia Virginia Beach, Virginia GREENLIGHT XPS TM A SYSTEMATIC APPROACH TO VAPORIZATION

More information

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano Dipartimento di Urologia Direttore Prof. Giorgio Guazzoni Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano alberto.saita@humanitas.it

More information

Transurethral Laser Technology: Treatments for BPH

Transurethral Laser Technology: Treatments for BPH Transurethral Laser Technology: Treatments for BPH Richard Lee, MD Departments of Urology and Public Health The New York Presbyterian Hospital Weill Medical College of Cornell University Background Traditional

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme Clinical guideline CG97: The management of lower urinary tract symptoms in men Publication date May

More information

Submitted: August 15, Accepted: September 10, Published: October 15, 2018.

Submitted: August 15, Accepted: September 10, Published: October 15, 2018. Original Article doi: 10.22374/jeleu.v1i2.21 THULIUM LASER ENUCLEATION OF THE PROSTATE (THULEP) AS A TECHNIQUE FOR TREATMENT OF BPH: EVALUATION OF A SIX-YEAR EXPERIENCE AT A SINGLE INSTITUTION Mahmood

More information

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments Benign Prostatic Hyperplasia: Update on Innovative Current Treatments Michael Ferrandino, MD As.soc Professor Director of Minimally Invasive Urologic Surgery Division of Urologic Surgery Duke University

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of insertion of prostatic urethral lift implants to treat lower urinary tract symptoms

More information

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP Introduction to Enlarged Prostate E. David Crawford, MD Professor of Surgery (Urology) and Radiation Oncology Head, Urologic Oncology E. David Crawford Endowed Chair in Urologic Oncology University of

More information

Hong Kong College of Surgical Nursing

Hong Kong College of Surgical Nursing Hong Kong College of Surgical Nursing Higher Surgical Nursing Training: Part B Specialty - Urological Nursing Curriculum TABLE OF CONTENTS No. Contents Page. Introduction. Aims. Learning Objectives 4.

More information

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists,

More information

LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital

LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital LUTS- Classification Men LUTS can be divided into: Storage Voiding Frequency Nocturia Urgency

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Medical technology guidance SCOPE The UroLift system for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia 1

More information

Benign Prostatic Hyperplasia. Management of Benign Prostatic Hyperplasia. Goals of Therapy

Benign Prostatic Hyperplasia. Management of Benign Prostatic Hyperplasia. Goals of Therapy Benign Prostatic Hyperplasia Management of Benign Prostatic Hyperplasia Goals of Therapy Improve or abolish lower urinary tract symptoms (LUTS) Prevent or delay clinical progression of benign prostatic

More information

AN OVERVIEW OF THE MANAGEMENT OF MALE LOWER URINARY TRACT SYMPTOMS AND BENIGN PROSTATIC OBSTRUCTION

AN OVERVIEW OF THE MANAGEMENT OF MALE LOWER URINARY TRACT SYMPTOMS AND BENIGN PROSTATIC OBSTRUCTION AN OVERVIEW OF THE MANAGEMENT OF MALE LOWER URINARY TRACT SYMPTOMS AND BENIGN PROSTATIC OBSTRUCTION *Richard Christian Rowan Nayar, Hashim Hashim Continence and Urodynamics Unit, Bristol Urological Institute,

More information

Erectile dysfunction. By Anas Hindawi Supervised by Dr Khalid AL Sayyid

Erectile dysfunction. By Anas Hindawi Supervised by Dr Khalid AL Sayyid Erectile dysfunction By Anas Hindawi Supervised by Dr Khalid AL Sayyid ED is the persistent/recurrent inability to attain and/or maintain a penile erection rigid enough for satisfactory sexual intercourse

More information

EAU GUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation

EAU GUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation EAU GUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation (Partial text update March 2015) K. Hatzimouratidis (Chair), F. Giuliano, I. Moncada, A. Muneer, A. Salonia (Vice-chair),

More information

Managing lower urinary tract symptoms in men

Managing lower urinary tract symptoms in men Managing lower urinary tract symptoms in men MacKenzie KR, Aning JJ. Managing lower urinary tract symptoms in men. Practitioner 6; 6(79):-6 Mr Kenneth R MacKenzie MBChB MRCS (Ed) Core Trainee in Urology

More information

Management of LUTS after TURP and MIT

Management of LUTS after TURP and MIT Management of LUTS after TURP and MIT Hong Sup Kim Konkuk University TURP & MIT TURP : Gold standard MIT TUIP TUNA TUMT HIFU LASER Nd:YAG, ILC, HoLRP, KTP LUTS after TURP and MIT Improved : about 70% Persistent

More information

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA A Minimally Invasive Innovative Treatment What is the prostate? The prostate is an accessory organ of the male reproductive system.

More information

H6D-MC-LVHR Clinical Study Report Synopsis Page LVHR Synopsis (LY450190)

H6D-MC-LVHR Clinical Study Report Synopsis Page LVHR Synopsis (LY450190) H6D-MC-LVHR Clinical Study Report Synopsis Page 1 2. LVHR Synopsis H6D-MC-LVHR Clinical Study Report Synopsis Page 2 Clinical Study Report Synopsis: Study H6D-MC-LVHR Title of Study: A Randomized, Double-Blind,

More information

Wednesday 25 June Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario

Wednesday 25 June Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario Wednesday 25 June 14.30 15.30 Poster Session 9: BPH 1 Chairmen: M. Speakman and D. Rosario P080 Unreliable residual volume measurement after increased water load diuresis G. ALIVIZATOS, A. SKOLARIKOS,

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of transurethral water vapour ablation for lower urinary tract symptoms caused by

More information

Management of male LUTS in general practice

Management of male LUTS in general practice 17 Management of male LUTS in general practice MARK J. SPEAKMAN AND FAITH MCMEEKIN The initial management of lower urinary tract symptoms in men is usually carried out in primary care. The authors explain

More information

EFFICACY OF LASER SURGERY FOR BENIGN PROSTATIC HYPERPLASIA TREATMENT

EFFICACY OF LASER SURGERY FOR BENIGN PROSTATIC HYPERPLASIA TREATMENT EFFICACY OF LASER SURGERY FOR BENIGN PROSTATIC HYPERPLASIA TREATMENT Hasmeinda Medical faculty of Universitas Muhammadiyah Surakarta ABSTRACT Benign prostatic hyperplasia (BPH) is the most important cases

More information

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI Page 1 Page 2 treatment of benign prostatic hyperplasia treatment of benign prostatic pdf treatment of benign prostatic

More information

LUTS in the modern era. Dr Jon Rees Tyntesfield Medical Group

LUTS in the modern era. Dr Jon Rees Tyntesfield Medical Group LUTS in the modern era Dr Jon Rees Tyntesfield Medical Group In the past! Man with urinary symptoms = PROSTATISM Prostatism = TURP TURP unsuccessful = REDO TURP Redo TURP unsuccessful = can t help you!

More information

Prostate artery embolization (PAE) for benign prostatic enlargement (BPE) 1

Prostate artery embolization (PAE) for benign prostatic enlargement (BPE) 1 Prostate artery embolization (PAE) for benign prostatic enlargement (BPE) 1 Somani B K 1, Hacking N 2, Bryant T 2, Coyne J 2, Flowers D 2, Harris M 1, Dyer J 1. Department of Urology 1 and Interventional

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of transurethral water jet ablation for lower urinary tract symptoms caused by benign

More information

Chapter 3: Results of the Treatment Outcomes Analyses

Chapter 3: Results of the Treatment Outcomes Analyses Chapter 3: Results of the Treatment Outcomes Analyses Introduction To determine the appropriateness of individual therapies, as well as to develop practice recommendations, the American Urological Association

More information

Prostate Disease. Chad Baxter, MD

Prostate Disease. Chad Baxter, MD Prostate Disease Chad Baxter, MD Managing BPH and LUTS Chad Baxter, MD Department of Urology cbaxter@mednet.ucla.edu 33 nd Annual UCLA Intensive Course in Geriatric Medicine & Board Review Prevalence of

More information

BPH OVERVIEW / MANAGEMENT. Richard L Haddad Norwest Private Hospital 17 Oct 2018

BPH OVERVIEW / MANAGEMENT. Richard L Haddad Norwest Private Hospital 17 Oct 2018 BPH OVERVIEW / MANAGEMENT Richard L Haddad Norwest Private Hospital 17 Oct 2018 Introduction Learning outcomes; Develop a management plan for BPH patients Describe the new medical therapies in BPH and

More information

Lasers in Urology. Sae Woong Choi, Yong Sun Choi, Woong Jin Bae, Su Jin Kim, Hyuk Jin Cho, Sung Hoo Hong, Ji Youl Lee, Tae Kon Hwang, Sae Woong Kim

Lasers in Urology. Sae Woong Choi, Yong Sun Choi, Woong Jin Bae, Su Jin Kim, Hyuk Jin Cho, Sung Hoo Hong, Ji Youl Lee, Tae Kon Hwang, Sae Woong Kim www.kjurology.org http://dx.doi.org/10.4111/kju.2011.52.12.824 Lasers in Urology 120 W Greenlight HPS Laser Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia in

More information

Elements for a Public Summary

Elements for a Public Summary VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Benign prostatic hyperplasia (BPH), also called benign prostatic hypertrophy or benign prostatic obstruction, is a condition in

More information

NON-Neurogenic Chronic Urinary Retention AUA White Paper

NON-Neurogenic Chronic Urinary Retention AUA White Paper NON-Neurogenic Chronic Urinary Retention AUA White Paper Great Lakes SUNA Inside Urology March 16, 2018 Michelle J. Lajiness FNP-BC Nurse Practitioner DMC Urology Incidence Really unknown Lack consensus

More information

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon

The Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon Prostate case study Presented by Mr Alan Thompson Consultant Urological Surgeon 2 Part one Initial presentation A 62 year old male solicitor attends your GP surgery. He has rarely seen you over the last

More information

Prostate Artery Embolization

Prostate Artery Embolization Prostate Artery Embolization in the office interventional suite Robert J. Kennedy, M.D. Interventional & Vascular Center Melbourne, Florida The speaker has no financial conflicts of interest to disclose.

More information

What can the primary care physician do? Brian W. Ellis

What can the primary care physician do? Brian W. Ellis What can the primary care physician do? Brian W. Ellis Consultant Urological Surgeon at Ashford & St Peter s 1983-2007 Currently Consultant Urological Surgeon at Cobham Hospital Visiting Professor at Middlesex

More information

UroLift for treating the symptoms of benign prostatic hyperplasia

UroLift for treating the symptoms of benign prostatic hyperplasia NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Medical technology guidance Assessment report overview UroLift for treating the symptoms of benign prostatic hyperplasia This assessment report overview

More information

Prostate Artery Embolization: A Minimally Invasive Option for the Treatment of BPH

Prostate Artery Embolization: A Minimally Invasive Option for the Treatment of BPH Prostate Artery Embolization: A Minimally Invasive Option for the Treatment of BPH Farrah J. Wolf, MD Diagnostic Radiology, Board Certified Vascular & Interventional Radiology fwolf@bocaradiology.com Educational

More information

Chapter 3: Results of the Treatment Outcomes Analyses

Chapter 3: Results of the Treatment Outcomes Analyses Chapter 3: Results of the Treatment Outcomes Analyses TABLE OF CONTENTS INTRODUCTION... 3 WATCHFUL WAITING... 11 STUDY OUTCOMES... 11 MEDICAL THERAPIES... 13 ALPHA-ADRENERGIC ANTAGONISTS (ALPHA-BLOCKERS)...

More information

HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION.

HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION. IN YOUR HANDS HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION. Main Application Fields UROLOGY GENERAL SURGERY ENT LASER AT YOUR SIDE IN YOUR HANDS is a high power holmium laser

More information

Victoria Sharp, MD, MBA, FAAFP. Clinical Professor of Urology and Family Medicine

Victoria Sharp, MD, MBA, FAAFP. Clinical Professor of Urology and Family Medicine Victoria Sharp, MD, MBA, FAAFP Clinical Professor of Urology and Family Medicine Victoria Sharp, MD, MBA, FAAFP Market Chief Medial Officer AmeriHealth Caritas Family of Companies Office phone: (515) 330-3740

More information

Review Article A Personal Reflection of Greenlight 532 nm Laser for BPH Treatment

Review Article A Personal Reflection of Greenlight 532 nm Laser for BPH Treatment Advances in Andrology, Article ID 207901, 6 pages http://dx.doi.org/10.1155/2014/207901 Review Article A Personal Reflection of Greenlight 532 nm Laser for BPH Treatment Bilal Chughtai, Claire Dunphy,

More information

Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate

Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate Singapore Med J 2016; 57(12): 676-680 doi: 10.11622/smedj.2016026 Early outcome of transurethral enucleation and resection of the prostate versus transurethral resection of the prostate Sundaram Palaniappan

More information

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes The Management of BPH & The Impact of Combination Therapy Results Combination of Avodart and Tamsulosin (CombAT) Medical Therapy of Prostate Symptoms (MTOPS) Dr. Jack Barkin, md, fics, facs, dabu, Mcert

More information

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE 1 Approved by the AUA Board of Directors May 2018 Authors disclosure of potential conflicts of interest and author/staff contributions appear at the end of the article. 2018 by the American Urological

More information

National Institute for Health and Care Excellence. Lower Urinary Tract Symptoms Update Addendum Consultation Table 3 rd February 5 pm 3 rd March 2015

National Institute for Health and Care Excellence. Lower Urinary Tract Symptoms Update Addendum Consultation Table 3 rd February 5 pm 3 rd March 2015 British Association of Urological Surgeons British Association of Urological Surgeons National Institute for Health and Care Excellence Lower Urinary Tract Symptoms Update Addendum Consultation Table 3

More information

Prostatic Urethral Lift

Prostatic Urethral Lift Prostatic Urethral Lift Policy Number: 7.01.151 Last Review: 10/2018 Origination: 10/2015 Next Review: 10/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Prostatic

More information

UROLOGY TOPICS FOR SENIOR CLERKSHIP HEMATURIA

UROLOGY TOPICS FOR SENIOR CLERKSHIP HEMATURIA UROLOGY TOPICS FOR SENIOR CLERKSHIP HEMATURIA Blood in urine is an important presenting symptom for many diseases of the urinary tract as well as for systemic disorders. Degree of hematuria has poor correlation

More information

HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION. Main Application Fields UROLOGY GENERAL SURGERY ENT

HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION. Main Application Fields UROLOGY GENERAL SURGERY ENT IN YOUR HANDS HOLMIUM:YAG LASER WHEN POWERFUL VERSATILITY INTEGRATES UNMATCHED PRECISION. Main Application Fields UROLOGY GENERAL SURGERY ENT Manufactured by Asclepion Laser Technologies GmbH LASER AT

More information

Name of Policy: Transurethral Microwave Thermotherapy

Name of Policy: Transurethral Microwave Thermotherapy Name of Policy: Transurethral Microwave Thermotherapy Policy #: 449 Latest Review Date: September 2013 Category: Surgery Policy Grade: B Background/Definitions: As a general rule, benefits are payable

More information

Medical technologies guidance Published: 16 September 2015 nice.org.uk/guidance/mtg26

Medical technologies guidance Published: 16 September 2015 nice.org.uk/guidance/mtg26 UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia Medical technologies guidance Published: 16 September 2015 nice.org.uk/guidance/mtg26 NICE 2018. All rights reserved. Subject

More information

GUIDELINES ON ERECTILE DYSFUNCTION

GUIDELINES ON ERECTILE DYSFUNCTION GUIDELINES ON ERECTILE DYSFUNCTION (Text updated March 2005) E. Wespes (chairman), E. Amar, D. Hatzichristou, K. Hatzimouratidis, F. Montorsi, J. Pryor, Y. Vardi 88 Erectile Dysfunction Eur Urol 2001;40:97-101

More information

Original Article - Lasers in Urology. Min Ho Lee, Hee Jo Yang, Doo Sang Kim, Chang Ho Lee, Youn Soo Jeon

Original Article - Lasers in Urology. Min Ho Lee, Hee Jo Yang, Doo Sang Kim, Chang Ho Lee, Youn Soo Jeon www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.11.737 Original Article - Lasers in Urology http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.11.737&domain=pdf&date_stamp=2014-11-16

More information

Control & confidence. You deserve both. YOUR GUIDE TO THE TREATMENT OF BPH

Control & confidence. You deserve both. YOUR GUIDE TO THE TREATMENT OF BPH Control & confidence. You deserve both. YOUR GUIDE TO THE TREATMENT OF BPH The more you know, the better you ll feel. You ve likely had a discussion with your doctor about BPH 1. What follows are some

More information

Control & confidence. You deserve both.

Control & confidence. You deserve both. Learn more about BPH and Plasma therapy Control & confidence. You deserve both. YOUR GUIDE TO THE TREATMENT OF BPH Your doctor is always happy to offer all the guidance you need so that you feel completely

More information

for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology

for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology Tadalafil 5 mg once daily for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology Why this conference? Not promotional but educational The pharmacist regularly

More information

Association of BPH with OAB: The Plumbing or the Pump?

Association of BPH with OAB: The Plumbing or the Pump? Association of BPH with OAB: The Plumbing or the Pump? Ryan P. Terlecki, MD FACS Associate Professor of Urology Director, Men s Health Clinic Director, GURS Fellowship in Reconstructive Urology, Prosthetic

More information

Executive Summary. Non-drug local procedures for treatment of benign prostatic hyperplasia 1. IQWiG Reports - Commission No.

Executive Summary. Non-drug local procedures for treatment of benign prostatic hyperplasia 1. IQWiG Reports - Commission No. IQWiG Reports - Commission No. N04-01 Non-drug local procedures for treatment of benign prostatic hyperplasia 1 Executive Summary 1 Translation of the executive summary of the final report Nichtmedikamentöse

More information

Overactive Bladder Syndrome

Overactive Bladder Syndrome Overactive Bladder Syndrome behavioural modifications to pharmacological and surgical treatments Dr Jos Jayarajan Urologist Austin Health, Eastern Health Warringal Private, Northpark Private, Epworth Overactive

More information